Hodgson J M, Cohen M D, Szentpetery S, Thames M D
Department of Internal Medicine (Cardiology), Medical College of Virginia, Richmond.
Circulation. 1989 Apr;79(4):797-809. doi: 10.1161/01.cir.79.4.797.
Our purpose was to determine if there are basal adrenergic influences on the coronary circulation in humans. We studied 56 patients with denervated hearts after cardiac transplantation and 19 normally innervated patients with angiographically normal coronary arteries. Coronary blood flow velocity was measured during cardiac catheterization with a subselective 3F intracoronary Doppler catheter. Heart rate was controlled by atrial pacing. Epicardial coronary artery diameter was measured by automated analysis of digital coronary angiograms. Coronary flow reserve was assessed by intracoronary papaverine hydrochloride (12 mg) injections. Regional sympathetic blockade was produced by intracoronary injections of phentolamine (3 mg, alpha) and propranolol (2 mg, beta) or metoprolol (3 mg, beta 1). After alpha-blockade, mean arterial pressure fell significantly (p less than 0.05) in both the denervated transplant (-5.8 +/- 1.5%) (mean +/- SEM) and normally innervated patients (-12.6 +/- 3.2%). Reductions in coronary flow velocity also were observed in these groups (-8.2 +/- 2.3% and -9.2 +/- 5.8%, respectively). Calculated coronary vascular resistance was unchanged. Similar changes were seen when patients were pretreated with beta-blockade before alpha-blockade. Nonspecific beta-blockade did not affect mean arterial pressure but decreased coronary velocity (innervated, -11.6 +/- 3.9%; denervated, -9.3 +/- 2.4%) and increased coronary vascular resistance (innervated, 15.4 +/- 6.7%; denervated, 10.2 +/- 3.7%). Coronary vascular resistance did not rise in either group after selective beta 1-blockade with metoprolol. Coronary flow reserve did not change in either patient group after either alpha- or beta-blockade. Changes in epicardial coronary artery diameter were small and generally not significant. These data suggest that alpha-receptor-mediated vascular tone is negligible in both denervated transplant patients and normally innervated patients. Additionally, the increase in vascular resistance after nonselective beta-blockade is the result of direct beta 2 vascular effects. Our data further suggest that there is little adrenergically mediated epicardial artery tone (either humoral or neural) at rest and that maximal vasodilator responses are not limited by adrenergically mediated vasomotor tone.
我们的目的是确定人体冠状动脉循环是否受到基础肾上腺素能的影响。我们研究了56例心脏移植后心脏去神经支配的患者以及19例冠状动脉造影正常的正常神经支配患者。在心脏导管插入术中,使用3F亚选择性冠状动脉内多普勒导管测量冠状动脉血流速度。通过心房起搏控制心率。通过对数字冠状动脉造影进行自动分析来测量心外膜冠状动脉直径。通过冠状动脉内注射盐酸罂粟碱(12毫克)评估冠状动脉血流储备。通过冠状动脉内注射酚妥拉明(3毫克,α)和普萘洛尔(2毫克,β)或美托洛尔(3毫克,β1)产生局部交感神经阻滞。α受体阻滞后,去神经支配的移植患者(-5.8±1.5%)(平均值±标准误)和正常神经支配患者(-12.6±3.2%)的平均动脉压均显著下降(p<0.05)。这些组中也观察到冠状动脉血流速度降低(分别为-8.2±2.3%和-9.2±5.8%)。计算得出的冠状动脉血管阻力未改变。当患者在α受体阻滞前先用β受体阻滞剂预处理时,也观察到类似变化。非特异性β受体阻滞剂不影响平均动脉压,但降低冠状动脉速度(神经支配组,-11.6±3.9%;去神经支配组,-9.3±2.4%)并增加冠状动脉血管阻力(神经支配组,15.4±6.7%;去神经支配组,10.2±3.7%)。用美托洛尔进行选择性β1受体阻滞后,两组的冠状动脉血管阻力均未升高。α受体或β受体阻滞后,两组患者的冠状动脉血流储备均未改变。心外膜冠状动脉直径的变化很小,通常不显著。这些数据表明,α受体介导的血管张力在去神经支配的移植患者和正常神经支配患者中均可忽略不计。此外,非选择性β受体阻滞后血管阻力的增加是直接β2血管效应的结果。我们的数据进一步表明,静息时几乎没有肾上腺素能介导的心外膜动脉张力(无论是体液性还是神经性),并且最大血管舒张反应不受肾上腺素能介导的血管运动张力的限制。